Cyclophosphamide and Peripheral motor neuropathy - a phase IV clinical study of FDA data
We study 169,775 people who have side effects when taking Cyclophosphamide. Peripheral motor neuropathy is found, especially among people who are female, 60+ old, have been taking the drug for < 1 month, also take Methotrexate and have Non-hodgkin's lymphoma.
The phase IV clinical study analyzes which people take Cyclophosphamide and have Peripheral motor neuropathy. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
What are phase IV trials?
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
169,775 people reported to have side effects when taking Cyclophosphamide.
Among them, 201 people (0.12%) have Peripheral motor neuropathy.
What is Cyclophosphamide?
Cyclophosphamide has active ingredients of cyclophosphamide. It is used in multiple myeloma. Currently, eHealthMe is studying from 169,918 Cyclophosphamide users.
What is Peripheral motor neuropathy?
Peripheral motor neuropathy (muscles in the body become progressively weaker over months to years) is found to be associated with 745 drugs and 316 conditions by eHealthMe. Currently, we are studying 1,844 people who have Peripheral motor neuropathy.
Number of Cyclophosphamide and Peripheral motor neuropathy reports submitted per year:
Time on Cyclophosphamide when people have Peripheral motor neuropathy *:
Gender of people who have Peripheral motor neuropathy when taking Cyclophosphamide*:
Age of people who have Peripheral motor neuropathy when taking Cyclophosphamide *:
Common drugs people take besides Cyclophosphamide *:
Common side effects people have besides Peripheral motor neuropathy *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Cyclophosphamide and have Peripheral motor neuropathy?Check whether Peripheral motor neuropathy is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
How severe was Peripheral motor neuropathy and when was it recovered:
Expand to all the drugs that have ingredients of cyclophosphamide:
Alternative drugs to, pros and cons of Cyclophosphamide:
- Cyclophosphamide (169,918 reports)
Browse all side effects of Cyclophosphamide:a b c d e f g h i j k l m n o p q r s t u v w x y z
Peripheral motor neuropathy treatments and more:
- Peripheral motor neuropathy (1,844 reports)
Common drugs associated with Peripheral motor neuropathy:
All the drugs that are associated with Peripheral motor neuropathy:
- Peripheral motor neuropathy (745 drugs)
Common conditions associated with Peripheral motor neuropathy:
- Multiple myeloma: 157 reports
All the conditions that are associated with Peripheral motor neuropathy:
- Peripheral motor neuropathy (316 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on cyclophosphamide (the active ingredients of Cyclophosphamide) and Cyclophosphamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Amlodipine and Urosepsis - 26 seconds ago
- Ortho Tri-Cyclen and Naltrexone Hydrochloride drug interaction - 26 seconds ago
- Thiamine and Haldol drug interaction - 27 seconds ago
- Trulicity and Cyclosporine drug interaction - 29 seconds ago
- Tirosint-Sol and Heart Palpitations - 33 seconds ago
- Optimark and Pseudomonas Infection - 34 seconds ago
- Rocaltrol and Brintellix drug interaction - 37 seconds ago
- Cisplatin and Stable Angina - 43 seconds ago
- Zebeta and Fluticasone Propionate drug interaction - 51 seconds ago
- Abilify and Threatened Labor - 53 seconds ago